CAMBRIDGE, England–(BUSINESS WIRE)–Abzena plc (AIM:ABZA), a life sciences Group providing services and technologies that enable the development and manufacture of biopharmaceutical products, notes the announcement today of the acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) of Adheron Therapeutics (“Adheron”). Adheron was a privately held biotechnology company developing SDP051, a …